Sort   by:  
 Page size 
UnknownDarifenacin treatment for overactive bladder in patients who expressed dissatisfaction with prior extended-release antimuscarinic therapy.
Not available
S-EPMC2680263 | biostudies-literature
UnknownEffects of secukinumab on bone mineral density and bone turnover biomarkers in patients with ankylosing spondylitis: 2-year data from a phase 3 study, MEASURE 1.
Not available
S-EPMC8670267 | biostudies-literature
UnknownEffect of Secukinumab on Traditional Cardiovascular Risk Factors and Inflammatory Biomarkers: Post Hoc Analyses of Pooled Data Across Three Indications.
Not available
S-EPMC9127026 | biostudies-literature
UnknownAchievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies.
Not available
S-EPMC7991028 | biostudies-literature
UnknownSecukinumab efficacy on resolution of enthesitis in psoriatic arthritis: pooled analysis of two phase 3 studies.
Not available
S-EPMC6894120 | biostudies-literature
Sort   by:  
 Page size